Conestoga Capital Amends Mesa Labs Stake (SC 13G/A)
Ticker: MLAB · Form: SC 13G/A · Filed: Jan 5, 2024 · CIK: 724004
| Field | Detail |
|---|---|
| Company | Mesa Laboratories Inc /Co/ (MLAB) |
| Form Type | SC 13G/A |
| Filed Date | Jan 5, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**Conestoga Capital updated its Mesa Labs stake, keep an eye on institutional ownership.**
AI Summary
Conestoga Capital Advisors, LLC filed an amended SC 13G/A on January 5, 2024, indicating their ownership of MESA LABORATORIES, INC. common stock as of December 31, 2023. This is the tenth amendment to their Schedule 13G, filed under Rule 13d-1(b). This filing updates their previous disclosures regarding their stake in Mesa Laboratories, which is important for investors to track institutional ownership changes.
Why It Matters
This filing shows an institutional investor's updated position, which can signal their ongoing confidence or changing sentiment in the company, influencing other investors' decisions.
Risk Assessment
Risk Level: low — This is a routine update on institutional ownership and does not inherently indicate significant risk or opportunity.
Analyst Insight
Investors should note that Conestoga Capital Advisors, LLC continues to hold a position in Mesa Laboratories, Inc. This filing is an update, and further analysis of the full Schedule 13G/A (which is not fully provided here) would be needed to understand the exact change in their ownership percentage or share count, which could then inform investment decisions.
Key Players & Entities
- Conestoga Capital Advisors, LLC (company) — the reporting person filing the SC 13G/A
- MESA LABORATORIES INC /CO/ (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 5, 2024 (date) — the filing date of the SC 13G/A
- 59064R109 (other) — the CUSIP number for Mesa Laboratories, Inc. common stock
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as indicated by 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 10)*'.
Who is the reporting person in this filing?
The reporting person is Conestoga Capital Advisors, LLC, as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Conestoga Capital Advisors, LLC'.
What is the subject company whose shares are being reported?
The subject company is MESA LABORATORIES, INC /CO/, as identified under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MESA LABORATORIES INC /CO/' and 'MESA LABORATORIES, INC (Name of Issuer)'.
What was the date of the event that triggered this filing?
The date of the event which required the filing of this statement was December 31, 2023, as specified in the filing.
Under which rule was this Schedule 13G/A filed?
This Schedule 13G/A was filed under Rule 13d-1(b), as indicated by the checked box '[X] Rule 13d-1(b)'.
Filing Stats: 1,052 words · 4 min read · ~4 pages · Grade level 8.6 · Accepted 2024-01-05 09:48:10
Key Financial Figures
- $0.01 — S, INC (Name of Issuer) Common Stock, $0.01 Par Value (Title of Class of Securitie
Filing Documents
- mlaba10_10524.htm (SC 13G/A) — 32KB
- 0001085146-24-000033.txt ( ) — 34KB
(a)
ITEM 1(a). NAME OF ISSUER: MESA LABORATORIES, INC
(b)
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 12100 West Sixth Avenue Lakewood, Colorado 80228
(a)
ITEM 2(a). NAME OF PERSON FILING: Conestoga Capital Advisors LLC Conestoga Small Cap Fund
(b)
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 550 E. Swedesford Rd. Suite 120 Wayne, PA 19087
(c)
ITEM 2(c). CITIZENSHIP: Delaware Delaware
(d)
ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, $0.01 Par Value
(e)
ITEM 2(e). CUSIP NUMBER: 59064R109 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [X] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [X] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: ITEM 4. (a) Amount beneficially owned: 617,612 401,006 (b) Percent of class: 11.45% 7.44% (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: 578,463 401,006 (ii) shared power to vote or to direct the vote: None (iii) sole power to dispose or direct the disposition of: 617,612 401,006 (iv) shared power to dispose or to direct the disposition of: None ITEM 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five per